VB-111 in Surgically Accessible Recurrent/Progressive GBM

Clinical trial NCT04406272 · TERMINATED

Trial details

NCT number: NCT04406272
Sponsor: Dana-Farber Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Recurrent Glioblastoma

Start date: 2020-08-01
Primary completion: 2024-08-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.